Table 4.
POP-Q measurements and urinary incontinence symptoms at baseline, 3 and 12 months after surgery
| Variable | Baseline | 3 months postoperation |
12 months postoperation |
|
|---|---|---|---|---|
| Anatomic measures (data available for146 patients at baseline, 110 at 3 months, and 103 12 months after surgery) | Most distal vaginal point (leading edge) | |||
| ≤1 cm inside hymen | 0 (0%) | 90/110 (82%) | 75/103 (73%) | |
| ≤1 cm beyond hymen | 0 (0%) | 107/110 (97%) | 96/103 (93%) | |
| >1 cm beyond hymen | 146/146 (100%) | 3/110 (3%) | 7/103 (7%) | |
| TVL (cm) | 9 (8, 10) | 3 (3, 4) | 3 (2.5, 4) | |
| GH (cm) | 6 (4, 7) | 2 (1.5, 3) | 2 (1.5, 3) | |
| PB (cm) | 3 (2, 4) | 4 (4, 5.5) | 4 (4, 5) | |
| Urinary symptoms (denominator varies by time point) | Stress incontinence symptoms present | 105/140 (75%) | 63/136 (46%) | 62/131 (47%) |
| Bother with stress incontinence present | 75/139 (54%) | 26/135 (19%) | 18/130 (14%) | |
| UUI/OAB symptoms present | 91/140 (65%) | 43/136 (32%) | 50/131 (38%) | |
| Bother with UUI/OAB present | 58/140 (41%) | 16/136 (12%) | 20/131 (15%) |
Data presented as n (%) or median (interquartile range)
POP-Q Pelvic organ prolapse quantification, TVL total vaginal length, GH genital hiatus, PB perineal body